BrainZell

BrainZell

Private
StockholmHealthcare & Life Scienceshttps://brainzell.com

Last Round

Seed

Aug 27, 2024

Est. Valuation

$7.57M

Total Funding Raised

$1.6M

Momentum Score

50 /100

Company Overview

BrainZell is a biotechnology company that has developed a platform of cell-based models of the human brain for drug discovery and testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

human brain organoidsorganoid screeningdrug discovery platformhigh-throughput screeninginduced pluripotent stem cellsiPSCsCNS drug discoveryanimal testing alternativetoxicity testingneurosafety assessmentphenotypic screeningpreclinical models3D cell cultureorganoid-as-a-servicecustom assay developmentbrain-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BrainZell Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BrainZell Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedAug 27, 2024
AcceleratorJun 24, 2024

Key People

Founding team and executive leadership

Petra Szeszula

Chief Executive Officer, Co-Founder

Founding Team

BrainZell Investors

Notable investors and investment history

InvestorRounds
Life Science InvestSeed
Norrsken AcceleratorSeed, Accelerator
IndustrifondenSeed

BrainZell Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BrainZell Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BrainZell's valuation, stock price, and market status.

Firmographic Details

HeadquartersStockholm
Employee Range12
Year Founded2021
Last FundingAug 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.